CCRCB Seminar Programme 2009-2010
Date: Thursday, 10 June 2010
Seminar Speaker: Professor David Fernig,
Professor of Biological Chemistry, School of Biological Sciences, University of Liverpool, Liverpool, UK
Title of Lecture: “Getting to grips with the cellular microenvironment in health and disease”
Date: Thursday, 3 June 2010
Seminar Speaker: Professor Adrian Harris,
Cancer Research UK Professor of Medical Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, UK
Title of Lecture: “Mechanisms of response and resistance to anti-angiogenesis therapy”
Date: Friday, 28 May 2010
Seminar Speaker: Professor Michael Olson,
Beatson Institute for Cancer Research, Glasgow, Scotland
Title of Lecture: “ROCK and LIMK signalling in tumour growth and invasion”
Date: Thursday, 13 May 2010
Seminar Speaker: Dr Ultan McDermott,
CDF Group Leader and CRUK Clinician Scientist Cancer Genome Project,
Wellcome Trust Sanger Institute, Cambridge, UK
Title of Lecture: “Integrating genomic datasets and drug sensitivity in cancer: A model
for biomarker discovery”
Date: Thursday, 6 May 2010
Seminar Speaker: Dr Kevin Ryan,
Beatson Institute for Cancer Research, Glasgow, Scotland
Title of Lecture: “Apoptosis and Autophagy in cell death and cancer”
Date: Thursday, 29 April 2010
Seminar Speaker: Dr Michael Way,
Cell Motility Laboratory, Cancer Research UK, London Research Institute
Title of Lecture: “Using Vaccinia virus to understand signalling dynamics and regulation
of actin polymerization”
Date: Thursday, 15 April 2010
Seminar Speaker: Dr Lorenzo Manti,
Radiation Biophysics Laboratory, Department of Physical Sciences, University of Naples, Italy
Title of Lecture: “Stress-induced Premature Cellular Senescence: implications for
radiotherapy”
Date: Thursday, 25 March 2010
Seminar Speaker: Dr Doug Winton,
Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge
Title of Lecture: “Functional approaches to interrogating intestinal stem cells”
Date: Thursday, 25 February 2010
Seminar Speaker: Professor Nick La Thangue,
Chair of Cancer Biology, Laboratory of Cancer Biology, University of Oxford, UK
Title of Lecture: “The Cancer Cell Cycle and Drug Discovery”
Date: Thursday, 11 February 2010
Seminar Speaker: Dr Sharon Tooze,
Secretory Pathways Laboratory, Cancer Research UK, London Research Institute
Title of Lecture: “Trafficking and signalling in mammalian autophagy”
Date: Thursday, 28 January 2010
Seminar Speaker: Professor Alan Rickinson,
School of Cancer Sciences, College of Medical and Dental Sciences,
University of Birmingham, UK
Title of Lecture: “Living with Epstein-Barr Virus: where virology, immunology and oncology meet”
Date: Thursday, 14 January 2010
Seminar Speaker: Dr Chris Pepper,
Department of Haematology, School of Medicine, Cardiff University, Wales
Title of Lecture: “The biological significance of CD38 in CLL - new insights following lentiviral transduction”
Date: Thursday, 17 December 2009
Seminar Speaker: Dr Seamas Donnelly,
College of Life Sciences, St. Vincent's University Hospital, University College Dublin, Ireland
Title of Lecture: “Macrophage Migration Inhibitory factor (MIF), inflammation and
cancer”
Date: Thursday, 10 December 2009
Seminar Speaker: Professor John Kelly,
Division of Surgery and Interventional Science, UCL Medical School,
University College London
Title of Lecture: “Translational science and surgery”
Date: Friday, 4 December 2009
Seminar Speaker: Professor Chris Proud,
School of Biological Sciences, University of Southampton, UK
Title of Lecture: “mTOR: a ‘master regulator’ of cell function”
Date: Thursday, 19 November 2009
Seminar Speaker: Professor Paul Clarke,
Biomedical Research Institute, University of Dundee, Scotland, UK
Title of Lecture: “Control of apoptosis during mitosis”
Date: Friday, 13 November 2009
Seminar Speaker: Professor Charles Craddock,
Centre for Clinical Haematology University of Birmingham, Queen Elizabeth Medical Centre, UK
Title of Lecture: “New Drug and Transplant Therapies in AML”
Date: Thursday, 5 November 2009
Seminar Speaker: Dr Derek Brazil,
Centre for Vision and Vascular Science, Queen’s University Belfast
Title of Lecture: “Insulin signalling in development and disease”
Date: Monday, 2 November 2009
Seminar Speaker: Dr Olivier Micheau,
INSERM U866: University of Burgundy, Dijon, France
Title of Lecture: “Drug-induced sensitization to Apo2L/TRAIL primarily involves
enhanced DISC formation and caspase-8 activation”
Date: Monday, 2 November 2009
Seminar Speaker: Dr Andy Takle,
Director of Translational Research, Cancer Research UK, London, UK
Title of Lecture: “Potent and selective inhibitors of B-Raf Kinase”
Date: Thursday, 29 October 2009
Seminar Speaker: Professor Neil Perkins,
Department of Cellular and Molecular Medicine, School of Medical Sciences, University of
Bristol, UK
Title of Lecture: “Regulation of cancer cell proliferation and survival by NF-KB”
Date: Thursday, 22 October 2009
Seminar Speaker: Professor Richard Marais,
Professor of Molecular Oncology, Institute for Cancer Research, Chester Beattie Laboratories, London, UK
Title of Lecture: “B-RAF signalling in cancer: biology and therapeutics”
Date: Thursday, 8 October 2009
Seminar Speaker: Dr Brian Huntly,
Cambridge Institute for Medical Research, Cambridge, UK
Title of Lecture: “A myeloid medley: differentiation specific effects of oncogenes in
AML and MPN”
